Cardiac arrest is unique among cardiac ischemic syndromes in that all circulation must be generated external to the heart. Although, chest compressions deliver limited blood flow, it may be possible to take advantage of this cardiopulmonary resuscitation (CPR) low-flow state to "prime" the heart in advance of return of restoration of spontaneous circulation. Prior investigation has demonstrated improved cardiac function after perfusing the globally ischemic heart with a cardioprotective agent under low-flow perfusion conditions (modeling CPR flow).
reperfusion. Post-conditioning activates various cardioprotective mechanisms that reduce myocardial necrosis and improve functional recovery. (2) The underlying mechanism(s) responsible for post-conditioning are an area of great interest and research. Laboratory studies suggest that the post-conditioning intervention must occur in the first few minutes of reperfusion to be effective. This pathway ultimately leads to downstream inhibition of the mitochondrial permeability pore transition (mPTP). Activation of these pathways has shown significant cardioprotection with both pre-and post-conditioning in prolonged regional ischemia models. (5) Low Flow generated by cardiopulmonary resuscitation such as controlled reperfusion, can improve cardiac outcome, constitutes a powerful argument in support of utilizing perfusion strategies for ameliorating reperfusion injury. Whether such a strategy might be effective during cardiac arrest by CPR generated flow is still unknown. Based on current knowledge, such a strategy must not delay the priority to secure ROSC.
There are as yet no definitive studies to determine whether CPR-generated flow induces cardioprotection. In contrast to regional ischemia, cardiac arrest is a global ischemic insult without means to achieve precise control of reperfusion.
Currently the majority of out-of-hospital cardiac arrest patients fail to achieve adequate reperfusion and thereby ROSC. Overall survival to hospital discharge 
CPR Delivery of Pharmacologic Cardioprotection
A second potential strategy to utilize the CPR period is to begin delivery of cardioprotective agents to the heart in advance of the full reperfusion that occurs with ROSC ( figure 1) . CPR could potentially serve as a delivery mechanism to prime the heart with pharmacologic agents and thereby begin earlier activation of previously described pre-and post-conditioning cardioprotective pathways during the CPR low flow state or at the time of full reperfusion following ROSC.
Pharmacologic post-conditioning in the setting of cardiac arrest can potentially improve patient outcome by ameliorating post-resuscitation cardiac dysfunction and injury. However, at present it is not known whether delivery of a pharmacological agent under CPR low-flow conditions induces any cardioprotection at the time of ROSC (full reperfusion). In our recent work, we have used a specific neutrophil elastase inhibitor (Sivelestat), which has shown post-ischemic cardiac protection when delivered at the onset of reperfusion, to test for pharmacologic post-conditioning under low-flow conditions. In this study we utilized the isolated rat heart perfusion model in order to tightly control reperfusion conditions after 25 minutes of global ischemia. Three reperfusion groups were evaluated; 1) full reperfusion (75 mm Hg) for 60 minutes, 2) reperfusion with low-flow (4 ml/min) for 3 min and then full reperfusion for 60 minutes and 3) reperfusion with low-flow (4 ml/min) and Sivelestat (100 µg/mL) for 3 min and then full reperfusion for 60 minutes. In this model, we noted that low-flow perfusion after global ischemia with sivelestat significantly improved cardiac function and decreased infarct size, despite a 3 minute delay before instituting full reperfusion. (16) Sivelestat has been approved for use in treatment of acute lung injury in Japan ischemic cardioprotection in both blood and Krebs buffer perfused hearts. The existence of a neutrophil-independent mechanism is supported by a study showing that Sivelestat can cause endothelium-independent relaxation of porcine coronary strips. (19) Sivelestat is an ideal pharmacological post-conditioning drug for further investigation under CPR type conditions because of its safety and multi-organ beneficial effects, especially for the heart and lungs.
In clinical practice, the administration of a pharmacologic post-conditioning agent is potentially feasible through a readily placed intravenous catheter in the cardiac arrest victim at the onset of resuscitation. If CPR-generated low-flow can successfully perfuse the heart with pharmacologically active agents, prior to ROSC, this will open up an entirely different pharmacologic approach to treat the cardiac arrest patient. It will enable future resuscitation (and reperfusion) strategies to focus on enhancing cardioprotective signaling pathways during CPR as a strategy to optimize resuscitation of the cardiac arrest patient. CPR as a perfusion tool is not an optimal perfusion strategy as it is only a timesensitive temporizing measure until spontaneous circulation can be generated. In addition there is great variability among cardiac arrest subjects, as well as over time in the same subject. Consequently, CPR-generated flow may be too low or variable to reliably activate cardioprotective pathways and instead only add to the ongoing ischemic burden of the heart due to insufficient oxygen and substrate delivery. However, if low-flow induces some cardioprotection either through lowflow itself or by delivery of pharmacologic post-conditioning agents, strategies to augment or amplify these cardioprotective pathways may improve the overall survival of sudden cardiac arrest patients. Such an approach to CPR would constitute an entirely new research direction.
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Conclusions
The post-conditioning phenomenon has primarily been described in regional cardiac ischemia models and in PCI, under conditions in which reperfusion can be controlled. Unlike the regional ischemia of acute myocardial infarction, controlled reperfusion following cardiac arrest is not possible, particularly in the pre- Resuscitation Strategy utilizing cardiopulmonary resuscitation-generated flow to perfuse the heart with a pharmacologic conditioning agent. Perfusion of the heart would begin in advance of full reperfusion which would occur with restoration of spontaneous circulation (ROSC). Conditioning effects would be manifest as cardioprotection during the post-ROSC reperfusion period. CPR, cardiopulmonary resuscitation; ROSC, restoration of spontaneous circulation ; VF, ventricular fibrillation.
